The murder of UnitedHealthcare’s CEO has put health insurance companies in the spotlight. But insurers are just one piece of America’s broken and expensive health care system.
Cost of Care
3 Health Care Decisions Awaiting the Next President
The next U.S. president will have to make consequential choices about the Affordable Care Act, prescription drug prices and abortion.
Why Employers Are Turning to Primary Care as Health Care Costs Soar
Some companies are cutting out insurers and bringing clinics to the office to address rising health care costs.
Race to the Bottom: Where’s the Cavalry?
Some of the most powerful new medicines pose a host of challenges for drug companies trying to copy and sell similar versions on the cheap. Can those companies find a sustainable path forward, or will patients get left stuck paying exorbitant prices?
3 Big Threats to the Cheap, Effective Medicines That Underpin U.S. Health Care
The U.S. has relied on cheap, effective generic drugs for 40 years. Now that promise is under threat.
Race to the Bottom: Hard Bargain
America pays less, on average, than any other major country for our generic drugs. But selling essential medicines at such low prices comes with hidden costs — from quality problems to frequent shortages.
Race to the Bottom: Boom Times
In this first part of our three-part series “Race to the Bottom,” we trace the origins of America’s generic drug industry — groundbreaking, bipartisan legislation signed by President Ronald Reagan that saved us trillions and also got us into trouble.
The Fifth Branch: The Last Line of Care
We explore how Durham grapples with connecting people to long-term care and support, and where the city draws the line between crisis response and social services.
Is Private Equity Ruining Health Care? It’s Complicated
While stories of private equity firms running amok in health care are easy to find, new research paints a more nuanced picture.
The Hunt for Lasting Fixes to America’s Medical Debt Crisis
A major new study throws cold water on a popular approach to relieving medical debt, but the research also reveals a promising path forward.
